Penn CFAR Seminar Series
2002-2003 Academic Year

Date/Time

Speaker

Location

Wednesday
Sept 18, 2002
12:00 to 1:00 p.m.

*Thomas J. Hope, Ph.D.
Associate Professor, Microbiology and Immunology
University of Illinois, Chicago College of Medicine

Looking at HIV in a New Way: Adventures with Fluorescently Labeled Virions

Wednesday
Nov 20, 2002
4:00 p.m.

Harriet Robinson, Ph.D.
Chief, Microbiology and Immunology
Yerkes Regional Primate Research Center, Emory University

Grossman
Auditorium,
Wistar

New Hope for an HIV-1 Vaccine

Thursday
Nov 22, 2002
12:30 to 1:30 p.m.

Chris Petropoulos, Ph.D.
Vice President of Research and Development,
ViroLogic, Inc.

Auditorium,
BRB ll/lll

Evaluating HIV-1 Entry and Antibody Neutralization Using Recombinant Viruses that Express Envelope Proteins Derived from Patient Viruses

Wednesday
Dec 4, 2002
12:00 to 1:00 p.m.

*Andrew A. Lackner, DVM, Ph.D.
Director, Tulane National Primate Research Center
Professor of Microbiology, Immunology and Pathology
Tulane University Health Science Center

Insights Into the Pathogenesis of AIDS From the Macaque Model

Wednesday
Dec 11, 2002
8:00 a.m.
(CFAR/CHOP)

Ward Cates, M.D., M.P.H.
President
Family Health Institute and Family Health International

Stokes
Auditorium,
CHOP

Human Sexuality and HIV in the New Millenium

Thursday
Dec 12, 2002
12:30 to 1:30 p.m.

Dana Gabuzda, M.D.
Associate Professor, Dept. Cancer Immunology and AIDS
Dana-Farber Cancer Institute

Envelope-Receptor Interactions of Pathogenic HIV Variants

Thursday
Dec 19, 2002
12:30 to 1:30 p.m.

Daniel C. Douek, MRCP, Ph.D.
Section Chief, Laboratory of Immunology
Vaccine Research Center, NIAID/NIH

The Effects of HIV on the CD4 and CD8 T Cell Pools: Infection and Senescence

Thursday
Jan 16, 2003
12:30 to 1:30 p.m.

David Vlahov, Ph.D.
Director, Center for Urban Epidemiologic Studies
New York Academy

Evaluation of the New York State Expanded Syringe Access Program (ESAP)

Wednesday
January 22, 2003
12:00 to 1:00 p.m.

*Paul Bieniasz, Ph.D.
Staff Investigator
Aaron Diamond AIDS Research Center

Austrian
Auditorium,
CRB

Gag: Host Factor Interactions in Retroviral Replication

Thursday
Feb 6, 2003
12:30 to 1:30 p.m.

Laura A. Napolitano, M.D.
Staff Investigator
Gladstone Institute of Virology and Immunology,
Assistant Adjunct Professor
Department of Medicine, Division of Infectious Diseases
University of California, San Francisco

Wood Room,
JMB

The Regulation of T-Lymphopoiesis During HIV-1 Disease: Implications for Immune Reconstitution

Monday
Feb 17, 2003
12:00 to 1:00 p.m.

Nitin Saksena, M.Sc., Ph.D.
Principal Scientist, Retroviral Genetics Division
Center for Virus Research, Westmead Millennium Institute, Australia

Room 25,
BRB ll/lll

Non-Progressive HIV Disease

Wednesday
Feb 19, 2003
12:00 to 1:00 p.m.

*Dennis R. Burton, Ph.D.
Professor, Department of Immunology
The Scripps Research Institute

Austrian
Auditorium,
CRB

Neutralizing Antibodies and a Vaccine for HIV-1

Thursday
Feb 20, 2003
12:30 to 1:30 p.m.

Richard Marlink, M.D.
Executive Director
Harvard AIDS Institute

Auditorium,
BRB ll/lll

Access to HIV Care and Treatment in Africa: The Role of Research and Training Partnerships

Friday
Feb 21, 2003
12:30 to 1:30 p.m.

Robert Ryder, M.D.
Professor of Epidemiology and Infectious Diseases
University of North Carolina

Auditorium,
BRB ll/lll

Striking Differences in HIV Prevalences in Adjacent sub-Saharan African Countries: Clues for Prevention?

Thursday
March 20, 2003
12:30 to 1:30 p.m.

Gerald Friedland, M.D.
Professor of Medicine/Epidemiology/Public Health
Director, AIDS Program
Yale University

Auditorium,
BRB ll/lll

Integrating HIV Prevention and Care: Studies at the Interface of Behavior and Biology

Thursday
March 27, 2003
12:30 to 1:30 p.m.

Daria Hazuda, Ph.D.
Executive Director, Basic Research
Merck and Company, Inc.

Auditorium,
BRB ll/lll

Inhibitors of HIV-1 Integrase

Thursday
April 17, 2003
12:30 to 1:30 p.m.

David Thomas, M.D.
Associate Professor of Medicine/Allergy/Infectious Diseases
Johns Hopkins

Auditorium,
BRB ll/lll

Hepatitis C in the HIV-Infected Patient

Wednesday
April 23, 2003
12:00 to 1:00 p.m.

Mark Feinberg, M.D., Ph.D.
Professor of Medicine/Microbiology & Immunology
Emory University School of Medicine/ Emory Vaccine Research Center

Auditorium,
BRB ll/lll

How the Natural Host Species for AIDS Virus Infections Remain Happy and Healthy

Thursday
May 15, 2003
12:30 to 1:30 p.m.

Steven M. Wolinsky, M.D.
Professor of Medicine/Chief, Division of Infectious Diseases
The Feinberg School of Medicine, Northwestern University

Auditorium,
BRB ll/lll

Population Biology of HIV Antigen Presentation by Class I Molecules HLA

Thursday
June 12, 2003
12:30 to 1:30 p.m.

Sten Vermund, M.D., Ph.D.
Professor/Chair of Epidemiology
University of Alabama Center for AIDS Research

Auditorium,
BRB ll/lll

Translating Science to Practice: HIV Prevention in Zambian Children